Inventor

ANISH CHAKKUMKAL

DE10 patents

⚠️ This page may combine multiple inventors who share the name “ANISH CHAKKUMKAL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MAX PLANCK GESELLSCHAFT

7 patents

US10220083B2Mar 5, 2019

Vaccines against Streptococcus pneumoniae serotype 8

MAX PLANCK GESELLSCHAFT9 citations79

US10328141B2Jun 25, 2019

Synthetic vaccines against Streptococcus pneumoniae type 1

MAX PLANCK GESELLSCHAFT3 citations70

US10864261B2Dec 15, 2020

Synthetic vaccines against Streptococcus pneumoniae serotype 2

MAX PLANCK GESELLSCHAFT2 citations69

US10596272B2Mar 24, 2020

Vaccines against Streptococcus pneumoniae serotype 5

MAX PLANCK GESELLSCHAFT2 citations69

US10052373B2Aug 21, 2018

Protein and peptide-free synthetic vaccines against Streptococcus pneumoniae type 3

MAX PLANCK GESELLSCHAFT3 citations68

US10688169B2Jun 23, 2020

Vaccines against carbapenem-resistant Klebsiella pneumoniae

MAX PLANCK GESELLSCHAFT0 citations46

US10188718B2Jan 29, 2019

Vaccines against Streptococcus pneumoniae serotype 4

MAX PLANCK GESELLSCHAFT0 citations46

JANSSEN PHARMACEUTICALS INC

1 patent

US11591377B2Feb 28, 2023

Heterologous administration of tau vaccines

JANSSEN PHARMACEUTICALS INC2 citations70

MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WSS E V

1 patent

US9815889B2Nov 14, 2017

Antibodies for prevention and treatment of diseases caused by clostridium difficile

MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WSS E V3 citations67

SEEBERGER PETER H

1 patent

US9238669B2Jan 19, 2016

Oligosaccharides and oligosaccharide-protein conjugates derived from Clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools

SEEBERGER PETER H5 citations65